On October 30, 2024, a significant filing was made with the United States Securities and Exchange Commission by JSAF Holdings, LLC and Jacob Safier, indicating a substantial investment in T2 Biosystems, Inc. The Schedule 13G filing, dated November 6, 2024, reveals that JSAF Holdings and Jacob Safier, as the portfolio manager, collectively own 1,000,000 shares of T2 Biosystems' common stock, which represents 5.7% of the company based on the number of shares reported as outstanding in T2 Biosystems' latest quarterly report. The filing specifies that this ownership stake is not intended for the purpose of changing or influencing the control of T2 Biosystems, nor is it connected with any transaction with such purpose or effect. The address for both JSAF Holdings and Jacob Safier is listed as The Wolfson Group, One State Street Plaza, New York, NY. The filing emphasizes that the information provided is accurate to the best of the signatories' knowledge after reasonable inquiry.

On October 30, 2024, a significant filing was made with the United States Securities and Exchange Commission by JSAF Holdings, LLC and Jacob Safier, indicating a substantial investment in T2 Biosystems, Inc. The Schedule 13G filing, dated November 6, 2024, reveals that JSAF Holdings and Jacob Safier, as the portfolio manager, collectively own 1,000,000 shares of T2 Biosystems' common stock, which represents 5.7% of the company based on the number of shares reported as outstanding in T2 Biosystems' latest quarterly report. The filing specifies that this ownership stake is not intended for the purpose of changing or influencing the control of T2 Biosystems, nor is it connected with any transaction with such purpose or effect. The address for both JSAF Holdings and Jacob Safier is listed as The Wolfson Group, One State Street Plaza, New York, NY. The filing emphasizes that the information provided is accurate to the best of the signatories' knowledge after reasonable inquiry.